JEREMY O'CONNELL, PHd
cso and co-founder
As CSO at Juvena Therapeutics, Dr. O'Connell guides R&D strategy and strategic level experimental design and structure for all milestones. He personally leads the proteomics division of Juvena Therapeutics R&D.
Jeremy O’Connell is a proteomics and systems biology expert with numerous publications, a PhD from UT Austin, a postdoc at Harvard, and experience leading research teams.
Dr. O'Connell began research in the USDA Crop Research Division while completing his BS in Biochemistry from the University of Wisconsin-Madison. He went on the earn his PhD in the Marcotte Lab at UT Austin, focussing on predicting the changes in intracellular protein quaternary structure changes in response to cellular stress and age by means of mass spectrometry, high throughput imaging, and computational predictions.
During his postdoctoral fellowship at Harvard Medical school in the lab of Steven Gygi he leveraged both his and the Gygi lab’s immense proteomics datasets to build several machine learning classifiers focussing on predicting protein-protein interactions within the ubiquitin system, the best of which surpassed statistical methods by >10% (manuscript in preparation). He has spearheaded research projects in multiple tier one research institutions, including Harvard and Stanford, employing a combination of mass spectrometry and high throughput imaging as demonstrated in his 13 publications to date, several fellowships, and awards.